Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Time in rANge vs. Time in nOrmal Glycemia for Better Glycemic Control [NA]
A clinical trial is investigating time in range versus time in normal glycemia for improving glycemic control in diabetes; the study is not …
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: The Impact of Changing to a New Child- and Family-centered Outpatient Diabetes Clinic Focusing on Early Involvement of the Child With Diabetes, Training in Calmness Around Diabetes Management, Healthy Lifestyle, and Creating Peer-to-peer Networks [NA]
The trial update describes shifting to a new child- and family-centered outpatient diabetes clinic that emphasizes early involvement of the …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease [Phase 2]
A Phase 2 clinical trial investigating inflammation and stem cell approaches in diabetic nephropathy and chronic kidney disease is currently…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia [Phase 2]
A Phase 2 clinical trial evaluating a glucagon-like peptide-1 receptor agonist for diabetes management in children and adolescents with tran…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Endothelial Changes in Diabetic and Non-diabetic Patients Undergoing Phacoemulsification [NA]
Completed clinical trial update evaluating endothelial cell density changes in diabetic and non-diabetic patients undergoing cataract surger…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Effect of Acupressure on Blood Glucose And Anxiety in Elderly With Diabetes [NA]
A clinical trial registry entry evaluating whether acupressure can influence blood glucose and anxiety in elderly individuals with diabetes;…
-
EMA approval · 2026-01-26EMA Authorised: Zegalogue (dasiglucagon hydrochloride) — Zealand Pharma A/S
The EMA has authorised Zegalogue (dasiglucagon hydrochloride) from Zealand Pharma A/S for the emergency treatment of severe hypoglycaemia in…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Effect Of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitors on Body Mass Index After 3 Months of Use in Diabetic Patients [Phase 1]
This Phase 1 trial update assesses the effect of SGLT-2 inhibitors on body mass index after three months in patients with diabetes.
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Cmate Blood Glucose Analyzer: Clinical Comparison Study of Fasting Blood Glucose Levels in the Morning
A completed clinical trial evaluating how the Cmate Blood Glucose Analyzer compares with standard fasting morning glucose measurements in pe…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Is There a Benefit From Addition of Exercise in Diabetic Patients With ED Who Complain Low Vitamin D? [NA]
This clinical trial update from Cairo University investigates whether adding exercise benefits diabetic patients with erectile dysfunction w…
-
FDA approval · 2026-01-23FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)
FDA approved a supplemental application for AFREZZA (insulin human) submitted by Mannkind Corporation.
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Enhanced DPP-GLB to Promote Weight Loss Among Nonresponders in a Community-Based Lifestyle Intervention. [NA]
Results from a clinical trial evaluating an enhanced DPP-GLB approach to promote weight loss among nonresponders in a community-based lifest…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Insulin Detemir in Obesity Management [NA]
Clinical trial update on Vanderbilt University's study evaluating insulin detemir for obesity management; the trial is currently active but …
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Together Overcoming Diabetes - Great Plains [NA]
This entry reports a Johns Hopkins-led clinical trial for diabetes in the Great Plains region that is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Multimodal Cardiovascular Magnetic Resonance Imaging for Cardiometabolic Pre-HF and HFpEF
An ongoing clinical trial evaluating multimodal cardiovascular magnetic resonance imaging to characterize cardiometabolic pre-heart failure …
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: ASCEND: ApproacheS to CHC ImplEmeNtation of SDH Data Collection and Action
This clinical trials update announces the completion of Kaiser Permanente's ASCEND study, evaluating approaches to implementing social deter…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Impact GLP-1 Agonists Following Bariatric [Phase 4]
A Phase 4 clinical trial update evaluating the impact of GLP-1 receptor agonists after bariatric surgery. The study is currently recruiting …
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy
A University of Alabama at Birmingham trial is recruiting to evaluate a human induced pluripotent stem cell-based therapy aimed at repairing…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Urinary Function and Multimorbidity Risks: A Longitudinal Study in Beijing Community-Dwelling Elderly
A longitudinal observational study planned in Beijing to assess urinary function and multimorbidity risks in community-dwelling elderly; rec…
-
EMA approval · 2026-01-21EMA Authorised: Lyumjev (previously Liumjev) (insulin lispro) — Eli Lilly Nederland B.V.
EMA authorised Lyumjev (insulin lispro) by Eli Lilly Nederland B.V. for the treatment of diabetes mellitus.
-
EMA approval · 2026-01-21EMA Authorised: Liprolog (insulin lispro) — Eli Lilly Nederland B.V.
EMA authorised Liprolog (insulin lispro) for diabetes mellitus. The marketing authorisation holder is Eli Lilly Nederland B.V.; decision dat…
-
EMA approval · 2026-01-21EMA Authorised: Humalog (insulin lispro) — Eli Lilly Nederland B.V.
The European Medicines Agency authorised Humalog (insulin lispro) for the treatment of diabetes mellitus. The marketing authorisation holder…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS(A), US-NovoLog®, and EU-NovoRapid® [Phase 1]
Phase 1 study completed to demonstrate pharmacokinetic and pharmacodynamic similarity between NKF-INS(A) and reference insulins US-NovoLog a…
-
EMA approval · 2026-01-21EMA Authorised: Abasaglar (previously Abasria) (insulin glargine) — Eli Lilly Nederland B.V.
EMA authorized Abasaglar, a biosimilar insulin glargine, for diabetes mellitus. The marketing authorization holder is Eli Lilly Nederland B.…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Diabetes Screening in Patients on Long-Term Glucocorticoid Therapy
This clinical trial update describes a study assessing diabetes screening in patients on long-term glucocorticoid therapy, with recruitment …